ALEXANDRIA, Va., July 10 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'LYTSTARIQ' in its latest official gazette. The trademark application with the serial number 99659510 was filed on Feb. 18, 2026.
Here are the other related details:
Goods and Services: 5 - Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations for gene therapy for the treatment of ocular disease, such as Stargardt Disease; Pharmaceutical preparations for gene therapy for the treatment of Stargardt Disease
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Ocugen, Inc. 11 GREAT VALLEY PARKWAY MALVERN PA Pennsylvania 19355...